AydemirSAydınSŞAltınkayaOAksakalEÖzmenM. Evaluation of hematological and biochemical parameters that predict the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention. Angiology. 2025; 76(10):999-1009.
2.
FajarJKHeriansyahTRohmanMS. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: a meta-analysis. Indian Heart J. 2018;70(suppl 3):S406-18.
3.
WangLHuangSZhouQDouLLinD. The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: a meta-analysis. Clin Cardiol. 2024;47(2):e24238. doi:10.1002/clc.24238
4.
PellicciaFNiccoliGZimarinoM, et al. Pathophysiology and treatment of the no-reflow phenomenon in ST-segment elevation myocardial infarction: focus on low-dose fibrinolysis during primary percutaneous intervention. Rev Cardiovasc Med. 2023;24(12):365. doi:10.31083/j.rcm2412365
5.
GalassoGSchiekoferSD’AnnaC, et al. No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives. Angiology. 2014;65(3):180-9. doi:10.1177/0003319712474336
6.
AnnibaliGScroccaIAranzullaTCMeligaEMaiellaroFMusumeciG. “No-reflow” phenomenon: a contemporary review. J Clin Med. 2022;11(8):2233.
7.
ÇelikMCKarayiğitOOzkanCDoluAKKalçıkM. Relationship between systemic inflammation index and no-reflow phenomenon in patients with ST-segment elevation myocardial infarction. Angiology. 2023;74(4):387-94.
8.
ShenSQiuXYangC, et al. Prognostic importance of the Scottish inflammatory prognostic score in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study. BMC Cancer. 2024;24(1):1393.
9.
FengJWangLWangLYangXLouG. Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma. BMC Cancer. 2022;22(1):284.
10.
ÖzbeyazNBAlgülE. A new parameter in predicting contrast-induced nephropathy: Osaka prognostic score. Rev Assoc Med Bras (1992). 2024;70(7):e20240423.